Planned sale of 850 COST common shares under Rule 144
Rhea-AI Filing Summary
A shareholder has filed a notice of proposed sale of 850 shares of common stock under Rule 144, to be sold through Fidelity Brokerage Services LLC on or about 01/21/2026 on NASDAQ. The filing lists an aggregate market value of 838318.27 for these shares and notes that there were 443869411 shares outstanding at the time of the notice.
The securities to be sold were acquired from the issuer through restricted stock vesting as compensation, with 125 shares acquired on 10/22/2023 and 725 shares acquired on 10/22/2024, both fully paid as compensation on the respective acquisition dates. The person for whose account the securities are to be sold represents that they do not know of any undisclosed material adverse information about the issuer’s current or prospective operations.
Positive
- None.
Negative
- None.
FAQ
How many shares are being sold in this Rule 144 notice for COST?
The notice covers a proposed sale of 850 shares of common stock through Fidelity Brokerage Services LLC on NASDAQ.
What is the aggregate market value of the shares in this COST Rule 144 filing?
The filing states an aggregate market value of 838318.27 for the 850 common shares covered by the notice.
How and when were the COST shares to be sold under Rule 144 originally acquired?
The shares were acquired from the issuer via restricted stock vesting as compensation: 125 shares on 10/22/2023 and 725 shares on 10/22/2024, with compensation as the nature of payment on each date.
When is the planned sale date and on which exchange will the COST shares be sold?
The approximate date of sale listed is 01/21/2026, and the securities are expected to be sold on NASDAQ.
How many COST shares were outstanding at the time of this Rule 144 notice?
The filing reports 443869411 shares of common stock outstanding at the time of the notice.
What representation does the selling person make in this COST Form 144 filing?
The person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.